Westside Current on MSN12h
Rakuten Medical Presented Research Results of Preclinical Studies for PD-L1-Targeted Photoimmunotherapy at The 83rd Annual Meeting of The Japanese Cancer Association 2024Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of photoimmunotherapy: depletion of PD-L1 expressing tumor cells and depletion ...
Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...
The findings, published in Nature Immunology, indicate that tumors edit the activity of multiple genes to avoid immune ...
A team led by Sylvain Meloche, Professor in the Faculty of Medicine at UdeM and Director of IRIC's Signaling and Cell Growth ...
Macquarie University researchers have discovered new information about how oral cancer cells may block the body's immune response. This could lead to better treatments for this aggressive disease.
Researchers at West Virginia University are advancing pancreatic cancer treatment by targeting a specific enzyme, ...
ME-01473 inhibited tumor growth in a patient-derived xenograft mouse model of non-small cell lung cancerElevated levels of soluble and ...
Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.
Research in zebrafish and mouse models reveals targeting EGLN2 could potentially reduce inflammation and slow down the progression of ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback